Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald Radich

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2024
Mutations and MRD: clinical implications of clonal ontogenyJerald Radich
Transplantation and Cellular Therapy|May 20, 2026
Portrait of a Pioneer: Fred AppelbaumJerald Radich
Seminars in Hematology|September 30, 2010
Stem cell transplant for chronic myeloid leukemia in the imatinib eraJerald Radich
Best Practice & Research. Clinical Haematology|August 25, 2009
The promise and pitfalls of gene expression studiesJerald Radich
Blood|July 11, 2015
Splicing up the classification of myelodysplasiaJerald Radich
American Journal of Hematology|November 24, 2022
Allogeneic transplantation for chronic myeloid leukemia: I'm not dead yet!Jerald Radich
British Journal of Haematology|July 4, 2020
Molecular testing of chronic myeloid leukaemia in low resource areasJerald Radich
Cancer Cell|July 9, 2010
The molecular biology of myeloproliferative disordersJerald Radich
Haematologica|April 24, 2019
Is DNA a better assay for residual disease in chronic myeloid leukemia?Jerald Radich
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
When to Consider Allogeneic Transplantation in CMLJerald Radich
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Hematology. American Society of Hematology. Education Program|December 7, 2024
Mutations and MRD: clinical implications of clonal ontogenyJerald Radich
Transplantation and Cellular Therapy|May 20, 2026
Portrait of a Pioneer: Fred AppelbaumJerald Radich
Seminars in Hematology|September 30, 2010
Stem cell transplant for chronic myeloid leukemia in the imatinib eraJerald Radich
Best Practice & Research. Clinical Haematology|August 25, 2009
The promise and pitfalls of gene expression studiesJerald Radich
Blood|July 11, 2015
Splicing up the classification of myelodysplasiaJerald Radich
American Journal of Hematology|November 24, 2022
Allogeneic transplantation for chronic myeloid leukemia: I'm not dead yet!Jerald Radich
British Journal of Haematology|July 4, 2020
Molecular testing of chronic myeloid leukaemia in low resource areasJerald Radich
Cancer Cell|July 9, 2010
The molecular biology of myeloproliferative disordersJerald Radich
Haematologica|April 24, 2019
Is DNA a better assay for residual disease in chronic myeloid leukemia?Jerald Radich
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
When to Consider Allogeneic Transplantation in CMLJerald Radich
Pageof 10